Circumferential parallel ligation for debulking of very large neurofibromas in patients with neurofibromatosis type 1
Rattachement africain : jp. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
BACKGROUND: Neurofibromatosis Type 1 (NF1) is a genetic disorder characterized by the presence of neurofibromas, including diffuse cutaneous and plexiform variants. In large lesions, debulking surgery is often indicated, but presents challenges due to the hypervascularity of the tumor and the risk of hemorrhage. Circumferential parallel ligation (CPL), originally developed for the management of vascular malformations, may be an effective approach for controlling hemorrhage during debulking surgery. METHODS: A retrospective review was conducted of 19 surgeries performed on 12 patients with NF1 and very large neurofibromas, between 2003 and 2024. All patients underwent debulking surgery using CPL. Data on tumor size, operative time, intra-operative blood loss, transfusion requirements, resection rate and post-operative complications were collected and analyzed. RESULTS: The mean tumor size was 26.6 cm, and the mean blood loss was 263.6 ml. Only two of the 19 surgeries required a blood transfusion. CPL was consistently effective in minimizing intra-operative hemorrhage without the use of specialized hemostatic devices. The mean resection rate was 71.9 %, indicating that significant tumor debulking was achieved in the majority of cases. Post-operative complications occurred in four surgeries but resolved with appropriate treatment. CONCLUSION: CPL is safe and effective for debulking large neurofibromas in patients with NF1, offering reliable hemostasis without requiring costly surgical devices.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Circumferential parallel ligation for debulking of very large neurofibromas in patients with neurofibromatosis type 1
- Date Crossref
- 01/05/2026
- Éditeur
- Elsevier BV
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
Niigata University Medical and Dental Hospital pays non établi dans la noticeÉtablissement de santé
-
Niigata University Division of Orthopedic Surgery pays non établi dans la noticeUniversité ou école supérieure
-
Uonuma kikan Hospital Department of Orthopedic Surgery pays non établi dans la noticeÉtablissement de santé
Niigata University Medical and Dental Hospital, Division of Orthopedic Surgery — Niigata University et Department of Orthopedic Surgery — Uonuma kikan Hospital.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.